` Comparison: ALVR vs ABBV - Alpha Spread

ALVR
vs
ABBV

Over the past 12 months, ALVR has underperformed ABBV, delivering a return of 0% compared to the ABBV's +6% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ALVR
ABBV
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ALVR Intrinsic Value
LOCKED
Unlock
ABBV Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Allovir Inc
NASDAQ:ALVR
11.47 USD
Abbvie Inc
NYSE:ABBV
217.49 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ALVR, ABBV

ALVR
ABBV
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Allovir Inc
Revenue
Abbvie Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ALVR, ABBV

ALVR
ABBV
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Allovir Inc
NASDAQ:ALVR
Abbvie Inc
NYSE:ABBV
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ALVR
0%
ABBV
71.6%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

Operating Margin

ALVR
0%
ABBV
34.2%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

Net Margin

ALVR
0%
ABBV
6.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

FCF Margin

ALVR
0%
ABBV
29.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

ROE

ALVR
-45.4%
ABBV
15 221.8%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

ROA

ALVR
-38%
ABBV
3.1%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

ROIC

ALVR
-108 349%
ABBV
14%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

ROCE

ALVR
-40.1%
ABBV
22.4%
LTM 3Y Avg 5Y Avg 10Y Avg
Allovir Inc
Abbvie Inc

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ALVR, ABBV

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALVR, ABBV

Performance Gap Between ALVR and ABBV
LOCKED
Unlock

Performance By Year
ALVR, ABBV

Loading
ALVR
ABBV
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ALVR to other stocks
PNEXF
Pharnext SCA
More expensive
vs ALVR
EXAS
Exact Sciences Corp
Cheaper
vs ALVR
AMGN
Amgen Inc
Cheaper
vs ALVR
GILD
Gilead Sciences Inc
Cheaper
vs ALVR
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett